Status:
COMPLETED
Clinical-pathological Characterization and Outcomes of Renal Cell Carcinoma in Latin American
Lead Sponsor:
Latin American Cooperative Oncology Group
Collaborating Sponsors:
Ipsen
Conditions:
Kidney Neoplasms
Eligibility:
All Genders
18+ years
Brief Summary
Observational study, retrospective and prospective, of an analytical nature. Data will be collected from medical records and/or through contact with physicians and institutions (secondary data collect...
Eligibility Criteria
Inclusion
- Patients ≥ 18 years of age;
- Proven histology of renal cell carcinoma (any subtype);
- Pathological diagnosis of renal cell carcinoma in January 2015 or later and new cases diagnosed during the period of recruitment of each center;
- Have the medical record available and suitable for collecting data on patient characteristics, treatment and outcome.
Exclusion
- Synchronous or other primary tumor within the last 3 years (except thyroid cancer or non melanoma skin).
Key Trial Info
Start Date :
September 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 11 2024
Estimated Enrollment :
211 Patients enrolled
Trial Details
Trial ID
NCT05184504
Start Date
September 1 2022
End Date
July 11 2024
Last Update
February 12 2025
Active Locations (16)
Enter a location and click search to find clinical trials sorted by distance.
1
CINPAM - Centro Integrado de Pesquisa da Amazônia
Manaus, Amazonas, Brazil, 69.020-030
2
Oncocentro Ceará (Rede D'or)
Fortaleza, Ceará, Brazil, 60.135-237
3
Hospital Evangélico de Cachoeiro de Itapemirim - Centro de Pesquisas Clínicas em Oncologia (CPCO)
Cachoeiro de Itapemirim, Espírito Santo, Brazil, 29.308-065
4
Santa Casa de Misericórdia de Feira de Santana
Feira de Santana, Estado de Bahia, Brazil, 44.051-754